Aortic dissection natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
New page: {{Template:Aortic dissection}} {{CMG}} '''Associate Editor-In-Chief:''' {{CZ}} == Natural History == If the patient remains untreated, the mortality is: * 1% per hour during the first ... |
No edit summary |
||
Line 4: | Line 4: | ||
'''Associate Editor-In-Chief:''' {{CZ}} | '''Associate Editor-In-Chief:''' {{CZ}} | ||
== Natural History == | == Natural History == | ||
Line 11: | Line 10: | ||
* 75% at 2 weeks | * 75% at 2 weeks | ||
* 90% at 1 year | * 90% at 1 year | ||
==Complications== | |||
The complications of aortic dissection include: | |||
*[[Hypotension]] and [[shock]] from a possible aortic rupture | |||
*[[Pericardial tamponade]] | |||
*[[Acute aortic regurgitation]]due to the aortic dissection generating into [[Valsalva]] with an aortic valve insufficiency | |||
*[[Pulmonary edema]] | |||
*[[Myocardial ischemia]] due to involvement from the right or left coronary ostium | |||
*[[Mesenteric]] and [[renal ischemia]]- can lead to [[hematuria]], [[renal infarction]], [[acute renal failure]], or visceral ischemia | |||
*[[Claudication]] due to an extension of the dissection into the iliac arteries | |||
*Redissection and aortic diameter enlargement | |||
*Aneurysmal dilatation and [[saccular aneurysm]] | |||
Neurologic findings include: | |||
*Ischemic cerebrovascular accident ([[CVA]]) | |||
*[[Hemiplegia]] | |||
*Hemianesthesia | |||
Compressive symptoms include: | |||
*[[Superior vena cava syndrome]] | |||
*[[Horner syndrome]] (involves superior cervical ganglia) | |||
*[[Dysphagia]] (involves the esophagus) | |||
*Airway compromise | |||
*[[Hemoptysis]] (involves the compression of the bronchus) | |||
*[[Vocal cord paralysis]] and hoarseness | |||
==Prognosis== | |||
*30% hospital-based mortality rates | |||
*60% 10-year survival rate when treated | |||
The mortality rate is conditional and based upon the patient's clinical condition. | |||
Type A aortic dissection | |||
:*surgical treatment-30% mortality rate | |||
:*medial treatment-60% mortality rate | |||
Type B aortic dissection | |||
:*surgical treatment-10% mortality rate | |||
:*medical treatment- 30% mortality rate | |||
== References == | == References == |
Revision as of 14:29, 13 July 2011
Aortic dissection Microchapters |
Diagnosis |
---|
Treatment |
Special Scenarios |
Case Studies |
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Natural History
If the patient remains untreated, the mortality is:
- 1% per hour during the first day
- 75% at 2 weeks
- 90% at 1 year
Complications
The complications of aortic dissection include:
- Hypotension and shock from a possible aortic rupture
- Pericardial tamponade
- Acute aortic regurgitationdue to the aortic dissection generating into Valsalva with an aortic valve insufficiency
- Pulmonary edema
- Myocardial ischemia due to involvement from the right or left coronary ostium
- Mesenteric and renal ischemia- can lead to hematuria, renal infarction, acute renal failure, or visceral ischemia
- Claudication due to an extension of the dissection into the iliac arteries
- Redissection and aortic diameter enlargement
- Aneurysmal dilatation and saccular aneurysm
Neurologic findings include:
- Ischemic cerebrovascular accident (CVA)
- Hemiplegia
- Hemianesthesia
Compressive symptoms include:
- Superior vena cava syndrome
- Horner syndrome (involves superior cervical ganglia)
- Dysphagia (involves the esophagus)
- Airway compromise
- Hemoptysis (involves the compression of the bronchus)
- Vocal cord paralysis and hoarseness
Prognosis
- 30% hospital-based mortality rates
- 60% 10-year survival rate when treated
The mortality rate is conditional and based upon the patient's clinical condition.
Type A aortic dissection
- surgical treatment-30% mortality rate
- medial treatment-60% mortality rate
Type B aortic dissection
- surgical treatment-10% mortality rate
- medical treatment- 30% mortality rate
References
Acknowledgements
The content on this page was first contributed by: David Feller-Kopman, MD and C. Michael Gibson M.S., M.D.